Managing oncology drug costs in a constrained environment.
作者信息
Clark Peter
机构信息
National Health Service England, London, United Kingdom.
出版信息
Clin Adv Hematol Oncol. 2019 Feb;17(2):90-93.
PMID:30845110
Abstract
摘要
相似文献
1
Managing oncology drug costs in a constrained environment.
Clin Adv Hematol Oncol. 2019 Feb;17(2):90-93.
2
ASCO Rx for high drug costs: doctors and patients need to talk.美国临床肿瘤学会应对高昂药价的处方：医生和患者需要沟通。
J Natl Cancer Inst. 2009 Nov 4;101(21):1441-4. doi: 10.1093/jnci/djp398. Epub 2009 Oct 14.
3
Value in Oncology: It Is in the Eyes of the Beholder.肿瘤学中的价值：因人而异。
J Natl Compr Canc Netw. 2019 Jan;17(1):2-5. doi: 10.6004/jnccn.2018.7092.
4
Seeking value as cancer drug costs soar.随着癌症药物成本飙升，寻求价值。
Cancer Discov. 2013 Aug;3(8):833-4. doi: 10.1158/2159-8290.CD-ND2013-018. Epub 2013 Aug 1.
5
Managed care & medical oncology: the focus is on value.管理式医疗与肿瘤医学：关注重点是价值。
J Natl Compr Canc Netw. 2010 Sep;8 Suppl 7:S28-37. doi: 10.6004/jnccn.2010.0132.
6
[The costs of oncology. Results of an innovative research].[肿瘤学的成本。一项创新性研究的结果]
Tumori. 2008 May-Jun;94(3):1-4.
7
Many new cancer drugs in the United Kingdom are facing negative NICE rulings.英国许多新型抗癌药物正面临英国国家卫生与临床优化研究所（NICE）的负面裁决。
J Clin Oncol. 2007 Jun 20;25(18):2635-6; author reply 2637-8. doi: 10.1200/JCO.2007.11.4272.
8
Keynote comment: Cancer drug pricing in the USA.主题评论：美国的抗癌药物定价
Lancet Oncol. 2006 Jun;7(6):444-5. doi: 10.1016/S1470-2045(06)70702-1.
9
Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.美国临床肿瘤学会关于340B药品定价计划的政策声明。
J Oncol Pract. 2014 Jul;10(4):259-63. doi: 10.1200/JOP.2014.001432. Epub 2014 Apr 15.
10
Reforming the payment system for medical oncology.改革肿瘤医学支付体系。
JAMA. 2013 Jul 17;310(3):261-2. doi: 10.1001/jama.2013.8127.
Zotero 插件